Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC)

S. Saadatmand, I.M. Obdeijn, E.J. Rutgers, J.C. Oosterwijk, R.A. Tollenaar, G.H. Woldringh, E. Bergers, C. Verhoef, E.A. Heijnsdijk, M.J. Hooning, H.J. Koning, M.M. Tilanus-Linthorst

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1729-1738
JournalInternational Journal of Cancer
Volume137
Issue number7
DOIs
Publication statusPublished - 2015

Cite this

Saadatmand, S., Obdeijn, I. M., Rutgers, E. J., Oosterwijk, J. C., Tollenaar, R. A., Woldringh, G. H., ... Tilanus-Linthorst, M. M. (2015). Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC). International Journal of Cancer, 137(7), 1729-1738. https://doi.org/10.1002/ijc.29534